NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

UnknownN/A

Sponsor: Shirley Ryan AbilityLab

Conditions: Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Relapse, Multiple Sclerosis, Relapsing-Remitting

Interventions: Camera Based Kinematic Analysis

Countries: United States

The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria:

* Diagnosis of relapsing form of MS (including relapsing-remitting MS and secondary progressive MS)
* Able to ambulate overground
* Relapse free for at least 1 month
* Age ≥18 and ≤ 75 years
* Participants using dalfampridine will be eligible if taking the same daily dose for at least 2 months prior to screening

Exclusion criteria:

\- Orthopedic injuries, fractures, surgeries or other conditions affecting locomotor function or weight bearing

Locations (1)

Chicago, Illinois, United States